ASTRO: Cancers that qualify for proton therapy limited

Share this content:

the ONA take:

The American Society for Radiation Oncology (ASTRO) has developed a model policy to provide guidance in the appropriate use of proton-beam therapy for cancer treatment. The list of criteria includes such factors as tissue toxicity and cumulative radiation exposure. ASTRO found evidence that proton therapy was warranted in a limited number of cancers, including ocular tumors, metastatic tumors of the spine, and patients with genetic syndromes that emphasize the importance of minimizing total radiation, among others.

ASTRO: Cancers that qualify for proton therapy limited
ASTRO: Cancers that qualify for proton therapy limited
Evidence to support reimbursement for proton-beam therapy remains limited to several relatively uncommon cancers, although some patients enrolled in clinical trials also should receive coverage consideration, according to the American Society for Radiation Oncology.
READ FULL ARTICLE From Medical Page Today
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs